Using C-Reactive Protein Measurements to Predict Treatment Failure in Native Vertebral Osteomyelitis: A Multisite Retrospective Cohort Study
Open Forum Infectious Diseases · 28.04.2026 · 13 (5)
DOI: 10.1093/ofid/ofag239 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 22.04.2026. Verfasst von Brendan Campbell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, University of Vermont Medical Center, Burlington, Vermont, USA. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The management of native vertebral osteomyelitis (NVO) can be challenging due to imperfect prognostic tools to predict treatment outcome. It is common practice to use serial serum C-reactive protein (CRP) to help decide treatment response, although limited evidence supports this practice. We evaluated whether CRP assessment predicts treatment failure in NVO.
Methods
We conducted a multisite retrospective cohort study at the University of Vermont Health Network among adults with NVO managed with ≥6 weeks of antibiotics and in whom there were ≥2 documented CRP values at least a week apart. The primary outcome was microbiologic or clinical failure of antibiotic therapy within 6 months of the initial diagnosis.
Results
Among 628 patients identified by the initial screening criteria, 143 met inclusion criteria. In univariate analyses, the median last CRP value differed between patients with treatment success and those with treatment failure (8.9 vs 21.0 mg/dL; P < .01), as did the median percent decrease from first to last CRP measurement (88.9% vs 76.9% reduction; P = .03). However, in multivariate analyses adjusting for Staphylococcus aureus infection and epidural abscess we observed only weak and nonsignificant associations between CRP values and treatment failure (odds ratios, 1.02 for median last CRP value [P = .06] and 0.99 for median percent difference (P = .11).
Conclusions
Serial CRP measurements were only weakly associated with treatment failure in NVO. This common clinical practice is likely of little value.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, University of Vermont Medical Center, Burlington, Vermont, USA.
ORCID-Profile: Brendan Campbell, Tim Lahey, Andrew J Hale
Zitieren
APA
Campbell, B., Lahey, T., & Hale, A. J. (2026). Using C-Reactive Protein Measurements to Predict Treatment Failure in Native Vertebral Osteomyelitis: A Multisite Retrospective Cohort Study. Open Forum Infectious Diseases, 13(5). https://doi.org/10.1093/ofid/ofag239
Vancouver
Campbell B, Lahey T, Hale AJ. Using C-Reactive Protein Measurements to Predict Treatment Failure in Native Vertebral Osteomyelitis: A Multisite Retrospective Cohort Study. Open Forum Infectious Diseases. 2026;13(5). doi:10.1093/ofid/ofag239
BibTeX
@article{Campbell2026,
author = {Campbell, Brendan and Lahey, Tim and Hale, Andrew J},
title = {Using C-Reactive Protein Measurements to Predict Treatment Failure in Native Vertebral Osteomyelitis: A Multisite Retrospective Cohort Study},
journal = {Open Forum Infectious Diseases},
year = {2026},
volume = {13},
number = {5},
doi = {10.1093/ofid/ofag239}
}
EUVIMED